Resolution of Ecchymotic Lesions due to Fluoxetine and Escitalopram after Introduction of Reboxetine

Antidepressants, frequently prescribed in depression and anxiety disorders, are known to be responsible for an increase in bleeding. Yet, it has rarely been reported that SSRI treatment has unfavorable effects on hemostasis. The most frequently reported side effects of SSRIs on the hematologic syste...

Full description

Bibliographic Details
Main Authors: Sibel Kocbiyik, Sedat Batmaz, Levent Turhan, Ozgur Ahmet Yuncu, Ali Caykoylu
Format: Article
Language:English
Published: Cukurova University 2015-03-01
Series:Çukurova Üniversitesi Tıp Fakültesi Dergisi
Subjects:
Online Access:http://www.scopemed.org/fulltextpdf.php?mno=183943
_version_ 1797905707270406144
author Sibel Kocbiyik
Sedat Batmaz
Levent Turhan
Ozgur Ahmet Yuncu
Ali Caykoylu
author_facet Sibel Kocbiyik
Sedat Batmaz
Levent Turhan
Ozgur Ahmet Yuncu
Ali Caykoylu
author_sort Sibel Kocbiyik
collection DOAJ
description Antidepressants, frequently prescribed in depression and anxiety disorders, are known to be responsible for an increase in bleeding. Yet, it has rarely been reported that SSRI treatment has unfavorable effects on hemostasis. The most frequently reported side effects of SSRIs on the hematologic system are prolonged bleeding time, impaired thrombocyte aggregation and activity. Here we present a case in whom ecchymotic lesions occurred with esscitalopram and fluoxetine, which disappeared with reboxetine. [Cukurova Med J 2015; 40(Suppl 1): 90-93]
first_indexed 2024-04-10T10:10:37Z
format Article
id doaj.art-e8811b875bdd4dd2a1e802a5f3b21537
institution Directory Open Access Journal
issn 0250-5150
language English
last_indexed 2024-04-10T10:10:37Z
publishDate 2015-03-01
publisher Cukurova University
record_format Article
series Çukurova Üniversitesi Tıp Fakültesi Dergisi
spelling doaj.art-e8811b875bdd4dd2a1e802a5f3b215372023-02-15T16:22:15ZengCukurova UniversityÇukurova Üniversitesi Tıp Fakültesi Dergisi0250-51502015-03-014019093183943Resolution of Ecchymotic Lesions due to Fluoxetine and Escitalopram after Introduction of ReboxetineSibel Kocbiyik0Sedat Batmaz1Levent Turhan2Ozgur Ahmet Yuncu3Ali Caykoylu4Ataturk Egitim ve Arastirma Hastanesi, Psikiyatri Klinigi, Ankara Gaziosmanpasa Universitesi Tip Fakultesi, Ruh Sagligi ve Hastaliklari Anabilim Dali, Tokat Kartal Lutfi Kirdar Egitim ve Arastirma Hastanesi, Psikiyatri Klinigi, istanbul Ankara Egitim ve Arastirma Hastanesi, Psikiyatri Klinigi, Ankara Yildirim Beyazit Universitesi Tip Fakultesi, Ruh Sagligi ve Hastaliklari Anabilim Dali, AnkaraAntidepressants, frequently prescribed in depression and anxiety disorders, are known to be responsible for an increase in bleeding. Yet, it has rarely been reported that SSRI treatment has unfavorable effects on hemostasis. The most frequently reported side effects of SSRIs on the hematologic system are prolonged bleeding time, impaired thrombocyte aggregation and activity. Here we present a case in whom ecchymotic lesions occurred with esscitalopram and fluoxetine, which disappeared with reboxetine. [Cukurova Med J 2015; 40(Suppl 1): 90-93]http://www.scopemed.org/fulltextpdf.php?mno=183943SSRIecchymotic lesionbleeding
spellingShingle Sibel Kocbiyik
Sedat Batmaz
Levent Turhan
Ozgur Ahmet Yuncu
Ali Caykoylu
Resolution of Ecchymotic Lesions due to Fluoxetine and Escitalopram after Introduction of Reboxetine
Çukurova Üniversitesi Tıp Fakültesi Dergisi
SSRI
ecchymotic lesion
bleeding
title Resolution of Ecchymotic Lesions due to Fluoxetine and Escitalopram after Introduction of Reboxetine
title_full Resolution of Ecchymotic Lesions due to Fluoxetine and Escitalopram after Introduction of Reboxetine
title_fullStr Resolution of Ecchymotic Lesions due to Fluoxetine and Escitalopram after Introduction of Reboxetine
title_full_unstemmed Resolution of Ecchymotic Lesions due to Fluoxetine and Escitalopram after Introduction of Reboxetine
title_short Resolution of Ecchymotic Lesions due to Fluoxetine and Escitalopram after Introduction of Reboxetine
title_sort resolution of ecchymotic lesions due to fluoxetine and escitalopram after introduction of reboxetine
topic SSRI
ecchymotic lesion
bleeding
url http://www.scopemed.org/fulltextpdf.php?mno=183943
work_keys_str_mv AT sibelkocbiyik resolutionofecchymoticlesionsduetofluoxetineandescitalopramafterintroductionofreboxetine
AT sedatbatmaz resolutionofecchymoticlesionsduetofluoxetineandescitalopramafterintroductionofreboxetine
AT leventturhan resolutionofecchymoticlesionsduetofluoxetineandescitalopramafterintroductionofreboxetine
AT ozgurahmetyuncu resolutionofecchymoticlesionsduetofluoxetineandescitalopramafterintroductionofreboxetine
AT alicaykoylu resolutionofecchymoticlesionsduetofluoxetineandescitalopramafterintroductionofreboxetine